Physician profile
Lori Lee Carson
NPI 1487261814
$1,164.66
in general payments reported to CMS, 2019-2025
13 companies · $99.38 in 2025
The $99.38 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $288 · 2024: $777 · 2025: $99.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.65 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $272.95 | 2024 | Nalu Neurostimulation System |
| Medical Device Business Services, INC. | $232.87 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.00 | 2023-2025 | Relistor |
| Averitas Pharma INC. | $108.75 | 2024 | Qutenza |
| Pfizer INC. | $81.55 | 2024 | |
| Collegium Pharmaceutical, INC. | $69.90 | 2024 | Belbuca |
| Ferring Pharmaceuticals INC. | $60.43 | 2024 | Euflexxa |
| Scilex Pharmaceuticals INC. | $59.00 | 2024 | |
| Abbott Laboratories | $51.04 | 2024 | Proclaim |
| Biotronik Nro, INC. | $23.81 | 2025 | Prospera |
| Electronic Waveform Lab, INC. | $22.99 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $19.18 | 2025 | |
| Vertos Medical, INC. | $12.19 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.